Home > Node

Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212

Sofia, Bulgaria, 2 October 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that in pursuance of a decision of the General meeting of Holders of Warrants (GMHW) held on 02.06.2023 and decision of the Board of Directors of SOPHARMA AD from a meeting held on 05.06.2023 and based on art. 195 and art. 196 of the Commercial Law (CL), art. 113, para. 2, item 2 of Law on public offering of securities (LPOS) and art.

English

A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the LPOS requiring prior approval by the public company

Sofia, Bulgaria, 29 September 2023 – According to the requirements of Art. 100t of the LPOS and in connection with Art. 114, para. 9 of the LPOS, "Sopharma" AD informs that, after a request made to the parent company, public company "Sopharma" AD by the subsidiary "Pharmalogistika" AD and consent given by the Board of Directors from 12.09.2023, today the subsidiary concluded the following transaction falling within the scope of Art. 114, para. 3 of the LPOS:

 

English

Pages